In This Week’s Issue:
1. The Data Mine: Tufts University Study Highlights Failure of Cost Effectiveness Analysis to Account for Variability Among Patients, click here to read the blog.
2. Opinion: Improving Children’s Medical Care Starts With Patient-Centered Research, click here to read the op-ed
3. The PCORI Blog: The Power of Collaboration in the Fight against Cardiovascular Disease, click here to read the blog.
4. Everyday Health: MS Treatments the Subject of PCORI-Funded Research, click here to read the blog.
5. HBR: We Won’t Get Value-Based Health Care Until We Agree on What “Value” Means, click here to read the article.
6. PCORI Seeking New Patient Engagement Advisory Panel Members, click here to apply
7. FDA Public Meeting: Evaluating Inclusion and Exclusion Criteria in Clinical Trials, click here to register.
8. Upcoming Events and Webinars, see details below.
9. Medical Journal Articles, see details below.
10. AHRQ Effective Program Updates, see details below.
1. The Data Mine: Tufts University Study Highlights Failure of Cost Effectiveness Analysis to Account for Variability Among Patients, click here to read the blog.
2. Opinion: Improving Children’s Medical Care Starts With Patient-Centered Research, click here to read the op-ed
3. The PCORI Blog: The Power of Collaboration in the Fight against Cardiovascular Disease, click here to read the blog.
4. Everyday Health: MS Treatments the Subject of PCORI-Funded Research, click here to read the blog.
5. HBR: We Won’t Get Value-Based Health Care Until We Agree on What “Value” Means, click here to read the article.
6. PCORI Seeking New Patient Engagement Advisory Panel Members, click here to apply
7. FDA Public Meeting: Evaluating Inclusion and Exclusion Criteria in Clinical Trials, click here to register.
8. Upcoming Events and Webinars, see details below.
9. Medical Journal Articles, see details below.
10. AHRQ Effective Program Updates, see details below.
1. The Data Mine: Tufts University Study Highlights Failure of Cost Effectiveness Analysis to Account for Variability Among Patients
PIPC’s newest blog series, The Data Mine, covers a new study confirming some of stakeholders’ most significant concerns about the utilization of cost-effectiveness research. “Results show that less than one quarter of the cost effectiveness studies reviewed (38 of the 200, or 19%) included the type of analysis that would recognize differences in even the most basic patient characteristics, such as age. Even among the subgroup of studies that did examine more specific patient groups, the level of analysis falls far short of what is optimal for helping patients make decisions about their treatment. Most of the 38 studies focused on only one difference among patient subgroups – age. Yet we know that gender, race, baseline risk, and numerous other factors influence treatment outcomes.” Click here to read the blog.
2. Opinion: Improving Children’s Medical Care Starts With Patient-Centered Research
PCORI Executive Director Joe Selby penned an op-ed in the Cincinnati Enquirer stressing a patient-centered approach to improving children’s medical care. “...During my talk at Cincinnati Children's, I emphasized how families here and across the country need patient-centered CER on a variety of diseases and conditions to continue. CER studies aren't designed to produce new drugs or procedures, but instead, complement such research by helping us make the most effective use of new discoveries as they become available to patients and clinicians.” Click here to read the op-ed.
3. The PCORI Blog: The Power of Collaboration in the Fight against Cardiovascular Disease
In The PCORI Blog, PCORI Executive Director Joe Selby and American Heart Association CEO Nancy Brown discuss the benefits PCORI and AHA’s collaboration on cardiovascular disease research. . “...PCORI and the American Heart Association each support groundbreaking research that improves treatment for heart disease, stroke, and vascular diseases...This week, we jointly hosted a briefing in Washington, DC, on the need to create evidence-based strategies for better prevention and treatment of cardiovascular disease. We also shared leading research from our partnership. We are jointly committed to research that provides information to help patients make informed choices about their individualized care options. One promising area for heart attack prevention discussed at the briefing was the reach and convenience that telehealth offers to help people with hypertension lower their blood pressure.” Click here to read the blog.
4. Everyday Health: MS Treatments the Subject of PCORI-Funded Research
In Everyday Health, Meryl Davids Landau reports on PCORI funded research that enables researchers to compare multiple sclerosis treatment approaches. “...With a dozen studies funded so far, MS is an important focus of PCORI research. Neurological diseases are the third most funded areas of research, behind the much more pervasive conditions of cancer and mental health problems. That's because in 2015, patients, researchers, groups like the National Multiple Sclerosis Society, and others came together to identify the areas most in need of research. Soon after, PCORI began accepting proposals to fill this void.” Click here to read the blog.
5. HBR: We Won’t Get Value-Based Health Care Until We Agree on What “Value” Means
Robert Pendleton writes in Harvard Business Review that value-based care can’t be achieved until there’s a clear definition of what value means. “At the micro level, we should leverage the growing power of physician- and hospital-review systems to gather more (and more-sophisticated) information on what is most valued by individual health care consumers. Our system alone collects more than 3,500 patient comments a week. Now we need to apply our growing computational capacities to deeply mine that data both within and among systems to create an enhanced patient experience that is informed by how they define value. And business leaders should expand their companies’ efforts to track and analyze — and educate their employees about — the multiple dimensions of value in the health benefit plans they offer.” Click here to read the article.
6. PCORI Seeking New Patient Engagement Advisory Panel Members
A fantastic opportunity for patient engagement! PCORI is now accepting applications and nominations for the 2018 Advisory Panel member selection cycle. “According to our authorizing legislation, advisory panels must include representatives of practicing and research clinicians, patients, and experts in scientific and health services research, health services delivery, and evidence-based medicine who have experience in the relevant topic, and, as appropriate, experts in integrative health and primary prevention strategies.” Click here to apply. Deadline: Friday, March 30.
7. FDA Public Meeting: Evaluating Inclusion and Exclusion Criteria in Clinical Trials
The FDA is folding a public meeting on April 16 to discuss how to improve eligibility criteria for clinical trials to better represent the broader patient population and increase diversity. “Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will bring the stakeholder community together to discuss a variety of topics related to eligibility criteria in clinical trials, their potential impact on patient access to investigational drugs, and how they might facilitate the enrollment of a diverse patient population. Other topics that will be addressed during the public meeting include alternative clinical trial designs that may increase enrollment of more diverse patient populations, as well as opportunities for using data from expanded access trials.” Click here to register.
8. Upcoming Events and Webinars
PCORI Board of Governors Meeting
March 20, 2018
Click here for details.
Advisory Panel on Rare Disease Spring 2018 Meeting
March 21, 2018
Click here for details.
PCORI Online: Pipeline to Proposal Awardee Webinar
March 22, 2018
Click here for details.
Webinar: Health Care Coverage Challenges: New Treatments With High Upfront Costs, Long-term Benefits and Delayed Savings
March 29, 2018
Click here for details.
Advisory Panel on Healthcare Delivery and Disparities Research Spring 2018 Meeting
April 11, 2018
Click here for details.
Advisory Panel on Patient Engagement Spring 2018 Meeting
April 19-20, 2018
Click here for details.
DIA 2018 Global Annual Meeting
June 24-28, 2018
Click here for details.
9. Medical Journal Articles
Data Collection of Patient Outcomes: One Institution's Experience, click here to view.
Frequency and Magnitude of Co-Payments Exceeding Prescription Drug Costs, click here to view.
Factors Contributing to Higher Health Care Spending in the United States Compared With Other High-Income Countries, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Increasing Uptake of Comparative Effectiveness and Patient-Centered Outcomes Research Among Stakeholders: Insights from Conference Discussion, click here to view.
Comparative Effectiveness and Patient-Centered Outcomes Research: Enhancing Uptake and Use by Patients, Clinicians and Payers, click here to view.
Comparative Effectiveness Research Requires Competitive Effectiveness, click here to view.
What Parents of Children With Complex Medical Conditions Want Their Child’s Physicians to Understand, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols, click here to view.
Ensuring the Patient Voice in Quality: An Educational Program for Patient Groups and Advocates, click here to view.
Patient-Reported Outcomes: Design with the End in Mind, click here to view.
Beliefs, Critical Thinking and Evidence-Based Medicine, click here to view.
Changes in patient-centered attitude and confidence in communicating with patients: a longitudinal study of resident physicians, click here to view.
January Issue: Journal of Comparative Effectiveness Research, click here to view.
Toward Patient-Centered Outcomes for Cognitive Evaluations: The Perspective of Those Affected by Parkinson's Disease, click here to view.
10. AHRQ Effective Program Updates
Patient or Participant Generated Registries, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Prioritization and Selection of Harms for Inclusion in Systematic Reviews, click here to view.
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents, click here to view.
A Framework for Conceptualizing Evidence Needs of Health Systems, click here to view.
Nonsurgical Treatments for Urinary Incontinence in Adult Women: A Systematic Review Update, click here to view.
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Management of Insomnia Disorder - Consumer and Clinician Summaries, click here to view
Harms of First-Line Depression Treatment in Older Adults, click here to view.
Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence - Clinician Summary, click here to view.
PIPC’s newest blog series, The Data Mine, covers a new study confirming some of stakeholders’ most significant concerns about the utilization of cost-effectiveness research. “Results show that less than one quarter of the cost effectiveness studies reviewed (38 of the 200, or 19%) included the type of analysis that would recognize differences in even the most basic patient characteristics, such as age. Even among the subgroup of studies that did examine more specific patient groups, the level of analysis falls far short of what is optimal for helping patients make decisions about their treatment. Most of the 38 studies focused on only one difference among patient subgroups – age. Yet we know that gender, race, baseline risk, and numerous other factors influence treatment outcomes.” Click here to read the blog.
2. Opinion: Improving Children’s Medical Care Starts With Patient-Centered Research
PCORI Executive Director Joe Selby penned an op-ed in the Cincinnati Enquirer stressing a patient-centered approach to improving children’s medical care. “...During my talk at Cincinnati Children's, I emphasized how families here and across the country need patient-centered CER on a variety of diseases and conditions to continue. CER studies aren't designed to produce new drugs or procedures, but instead, complement such research by helping us make the most effective use of new discoveries as they become available to patients and clinicians.” Click here to read the op-ed.
3. The PCORI Blog: The Power of Collaboration in the Fight against Cardiovascular Disease
In The PCORI Blog, PCORI Executive Director Joe Selby and American Heart Association CEO Nancy Brown discuss the benefits PCORI and AHA’s collaboration on cardiovascular disease research. . “...PCORI and the American Heart Association each support groundbreaking research that improves treatment for heart disease, stroke, and vascular diseases...This week, we jointly hosted a briefing in Washington, DC, on the need to create evidence-based strategies for better prevention and treatment of cardiovascular disease. We also shared leading research from our partnership. We are jointly committed to research that provides information to help patients make informed choices about their individualized care options. One promising area for heart attack prevention discussed at the briefing was the reach and convenience that telehealth offers to help people with hypertension lower their blood pressure.” Click here to read the blog.
4. Everyday Health: MS Treatments the Subject of PCORI-Funded Research
In Everyday Health, Meryl Davids Landau reports on PCORI funded research that enables researchers to compare multiple sclerosis treatment approaches. “...With a dozen studies funded so far, MS is an important focus of PCORI research. Neurological diseases are the third most funded areas of research, behind the much more pervasive conditions of cancer and mental health problems. That's because in 2015, patients, researchers, groups like the National Multiple Sclerosis Society, and others came together to identify the areas most in need of research. Soon after, PCORI began accepting proposals to fill this void.” Click here to read the blog.
5. HBR: We Won’t Get Value-Based Health Care Until We Agree on What “Value” Means
Robert Pendleton writes in Harvard Business Review that value-based care can’t be achieved until there’s a clear definition of what value means. “At the micro level, we should leverage the growing power of physician- and hospital-review systems to gather more (and more-sophisticated) information on what is most valued by individual health care consumers. Our system alone collects more than 3,500 patient comments a week. Now we need to apply our growing computational capacities to deeply mine that data both within and among systems to create an enhanced patient experience that is informed by how they define value. And business leaders should expand their companies’ efforts to track and analyze — and educate their employees about — the multiple dimensions of value in the health benefit plans they offer.” Click here to read the article.
6. PCORI Seeking New Patient Engagement Advisory Panel Members
A fantastic opportunity for patient engagement! PCORI is now accepting applications and nominations for the 2018 Advisory Panel member selection cycle. “According to our authorizing legislation, advisory panels must include representatives of practicing and research clinicians, patients, and experts in scientific and health services research, health services delivery, and evidence-based medicine who have experience in the relevant topic, and, as appropriate, experts in integrative health and primary prevention strategies.” Click here to apply. Deadline: Friday, March 30.
7. FDA Public Meeting: Evaluating Inclusion and Exclusion Criteria in Clinical Trials
The FDA is folding a public meeting on April 16 to discuss how to improve eligibility criteria for clinical trials to better represent the broader patient population and increase diversity. “Convened by the Duke-Robert J. Margolis, MD, Center for Health Policy at Duke University and supported by a cooperative agreement with FDA, this public event will bring the stakeholder community together to discuss a variety of topics related to eligibility criteria in clinical trials, their potential impact on patient access to investigational drugs, and how they might facilitate the enrollment of a diverse patient population. Other topics that will be addressed during the public meeting include alternative clinical trial designs that may increase enrollment of more diverse patient populations, as well as opportunities for using data from expanded access trials.” Click here to register.
8. Upcoming Events and Webinars
PCORI Board of Governors Meeting
March 20, 2018
Click here for details.
Advisory Panel on Rare Disease Spring 2018 Meeting
March 21, 2018
Click here for details.
PCORI Online: Pipeline to Proposal Awardee Webinar
March 22, 2018
Click here for details.
Webinar: Health Care Coverage Challenges: New Treatments With High Upfront Costs, Long-term Benefits and Delayed Savings
March 29, 2018
Click here for details.
Advisory Panel on Healthcare Delivery and Disparities Research Spring 2018 Meeting
April 11, 2018
Click here for details.
Advisory Panel on Patient Engagement Spring 2018 Meeting
April 19-20, 2018
Click here for details.
DIA 2018 Global Annual Meeting
June 24-28, 2018
Click here for details.
9. Medical Journal Articles
Data Collection of Patient Outcomes: One Institution's Experience, click here to view.
Frequency and Magnitude of Co-Payments Exceeding Prescription Drug Costs, click here to view.
Factors Contributing to Higher Health Care Spending in the United States Compared With Other High-Income Countries, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Increasing Uptake of Comparative Effectiveness and Patient-Centered Outcomes Research Among Stakeholders: Insights from Conference Discussion, click here to view.
Comparative Effectiveness and Patient-Centered Outcomes Research: Enhancing Uptake and Use by Patients, Clinicians and Payers, click here to view.
Comparative Effectiveness Research Requires Competitive Effectiveness, click here to view.
What Parents of Children With Complex Medical Conditions Want Their Child’s Physicians to Understand, click here to view.
PCORnet's Collaborative Research Groups, click here to view.
Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols, click here to view.
Ensuring the Patient Voice in Quality: An Educational Program for Patient Groups and Advocates, click here to view.
Patient-Reported Outcomes: Design with the End in Mind, click here to view.
Beliefs, Critical Thinking and Evidence-Based Medicine, click here to view.
Changes in patient-centered attitude and confidence in communicating with patients: a longitudinal study of resident physicians, click here to view.
January Issue: Journal of Comparative Effectiveness Research, click here to view.
Toward Patient-Centered Outcomes for Cognitive Evaluations: The Perspective of Those Affected by Parkinson's Disease, click here to view.
10. AHRQ Effective Program Updates
Patient or Participant Generated Registries, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Prioritization and Selection of Harms for Inclusion in Systematic Reviews, click here to view.
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents, click here to view.
A Framework for Conceptualizing Evidence Needs of Health Systems, click here to view.
Nonsurgical Treatments for Urinary Incontinence in Adult Women: A Systematic Review Update, click here to view.
Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update, click here to view.
Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors, click here to view.
Management of Insomnia Disorder - Consumer and Clinician Summaries, click here to view
Harms of First-Line Depression Treatment in Older Adults, click here to view.
Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence - Clinician Summary, click here to view.